Innovating Works

University Medicine Rostock

Desconocido
PlasmACT: Plasma Medicine against Actinic Keratosis UNIVERSITATSMEDIZIN ROSTOCK participó en un HORIZON EUROPE HORIZON-MSCA-2022-DN-01 The quality of human (and veterinary) health care systems substantially depends on key innovations. Often, these were driven by the field of...
2023-05-11 - 2027-12-31 | Financiado
CombiDiag: Peripheral Biomarker Based Combinatorial Early Diagnostics for Dementia UNIVERSITATSMEDIZIN ROSTOCK tramitó un HORIZON EUROPE HORIZON-MSCA-2021-DN-01 CombiDiag DN aims to develop an AI-data-driven peripheral biomarker based combinatorial diagnostic protocol for early stages of Alzheimers d...
2023-02-01 - 2027-01-31 | Financiado
ALIVER: Development of DIALIVE a novel Liver Dialysis Device for the treatment of patients with Acute on Ch... UNIVERSITATSMEDIZIN ROSTOCK participó en un H2020 H2020-SC1-2016-2017 Liver disease incidence is increasing and about 170K patients die from liver failure each year in Europe. In liver failure, the accumulation...
2016-12-01 - 2021-01-31 | Financiado
BBDiag: Blood Biomarker based Diagnostic Tools for Early Stage Alzheimer s Disease UNIVERSITATSMEDIZIN ROSTOCK participó en un H2020 H2020-MSCA-ITN-2016 Alzheimer’s disease (AD) affects more than 7 million people in Europe and this figure is expected to double every 20 years. Despite intensiv...
2016-09-12 - 2021-12-31 | Financiado
CoCA: Comorbid Conditions of Attention deficit hyperactivity disorder UNIVERSITATSMEDIZIN ROSTOCK participó en un H2020 H2020-PHC-2014-2015 Understanding mechanisms underlying comorbid disorders poses a challenge for developing precision medicine tools. Psychiatric disorders are...
2015-12-16 - 2021-06-30 | Financiado
IMPACT: Ion Molecule Processes for Analytical Chemical Technologies UNIVERSITATSMEDIZIN ROSTOCK participó en un H2020 H2020-MSCA-ITN-2015 Soft chemical-ionization mass-spectrometry (SCIMS) is an exquisitely sensitive analytical technique with applications to health, the environ...
2015-08-10 - 2019-12-31 | Financiado
Ageing with elegans: Validating C. elegans healthspan model for better understanding factors causing health and disease... UNIVERSITATSMEDIZIN ROSTOCK participó en un H2020 H2020-PHC-2014-2015 Healthspan (the life period when one is generally healthy and free from serious disease) depends on nature (genetic make-up) and nurture (en...
2015-04-09 - 2020-10-31 | Financiado
HEARTEN: A co operative mHEALTH environment targeting adherence and management of patients suffering from Hea... UNIVERSITATSMEDIZIN ROSTOCK participó en un H2020 H2020-PHC-2014-2015 HEARTEN will design, develop and validate an ICT co-operative environment that will enable the HF patients to achieve sustainable behavior c...
2014-12-05 - 2018-03-31 | Financiado
PRIMA-EDS: Polypharmacy in chronic diseases Reduction of Inappropriate Medication and Adverse drug events in e... UNIVERSITATSMEDIZIN ROSTOCK participó en un FP7 Background: Treatment of chronic diseases in the elderly with polypharmacy poses a threat to patient outcome and involves extensive costs. L...
Financiado
SMART-HIP: Sensor Based Detection of Implant Loosening in Total Hip Replacements UNIVERSITATSMEDIZIN ROSTOCK participó en un FP7 Ageing, sedentary behaviour,and obesity are predictors of osteoarthritis, and the combination of arthritis and obesity causes an undue stres...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.